30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Robert Salisbury

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 80% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Enzon Pharmaceuticals Inc May 1, 2005 - Oct. 8, 2013
Robert Salisbury's trades of Enzon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2008-11-14 2008-11-13
B Purchase
86,376 -37.9%
358.11
US$3,351,565 		86,376 -37.9% 358.11 US$3,351,565
2008-11-14 2008-11-13
B Purchase
56,232 -5.6%
152.32
US$2,439,282 		56,232 -5.6% 152.32 US$2,439,282
2008-11-14 2008-11-13
B Purchase
16,106 -45.8%
18.44
US$4,872,489 		16,106 -45.8% 18.44 US$4,872,489
2008-11-14 2008-11-13
B Purchase
600 +2.1%
3.20
US$1,920 		600 +2.1% 3.20 US$1,920
2008-11-14 2008-11-13
B Purchase
2,873 +11.4%
3.19
US$9,165 		2,873 +11.4% 3.19 US$9,165